The Clinical Efficacy of the Video Laryngeal Mask (SaCoVLM™) in Geriatric Patients: A Comparison With a Conventional Supraglottic Airway Device (Ambu®Auragain™)

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
ElderlyLaryngeal Mask AirwayGeneral Anesthesia
Interventions
DEVICE

SaCoVLM™

Patients will receive general anesthesia with their airways maintained with the SaCoVLM, which is a newer supraglottic airway device with a video port to directly visualize the upper airway.

DEVICE

Ambu®Auragain™

Patients will receive general anesthesia with their airways maintained with the Ambu Auragain, which is a conventional 2nd generation supraglottic airway device.

Trial Locations (1)

Unknown

RECRUITING

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER